Reagents for Glucagon and Incretin Research (R41/R42)
ArchivedNational Institutes of Health
Description
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Technology Transfer Research (STTR) grant applications from small business concerns (SBCs) in partnership with non-profit research institutions for funding to perform research leading to the development of: A) Validated, highly sensitive, and specific assays for plasma glucagon B) Reagents for manipulation of glucagon receptor activity in the pancreatic islet and other tissues C) Reagents to be used to improve our understanding of pancreatic alpha-cell biology particularly in response to glucagon and incretins D) Reagents and assays for the accurate expression and quantitation of functional incretin receptors in the endocrine/exocrine cells of the pancreas and relevant extrapancreatic tissues.
Who can apply
- Small businesses
Contact
NIH OER Webmaster <br/>FBOWebmaster@OD.NIH.GOV <br/>
FBOWebmaster@OD.NIH.GOV
- PostedMay 2, 2014
- ClosesApr 5, 2017
- CFDA93.847
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro